Vanguard Group Inc Biomerica Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Biomerica Inc stock. As of the latest transaction made, Vanguard Group Inc holds 169,010 shares of BMRA stock, worth $537,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,010
Previous 169,010
-0.0%
Holding current value
$537,451
Previous $52,000
84.62%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BMRA
# of Institutions
29Shares Held
1.13MCall Options Held
35.8KPut Options Held
11.9K-
Potomac Capital Management, Inc.168KShares$533,2860.37% of portfolio
-
Geode Capital Management, LLC Boston, MA157KShares$497,9330.0% of portfolio
-
Black Rock Inc. New York, NY149KShares$474,0770.0% of portfolio
-
Bulltick Wealth Management, LLC Miami, FL137KShares$436,1330.02% of portfolio
-
Granahan Investment Management, LLC Waltham, MA88KShares$279,7380.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $42.7M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...